Detalhe da pesquisa
1.
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [18F]FDG PET/CT and MRI.
Eur J Nucl Med Mol Imaging
; 48(12): 3951-3960, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050405
2.
[18F]FDG PET/CT can trigger relevant oncological management changes leading to favorable outcome in iodine-negative thyroid cancer patients.
Endocrine
; 84(2): 656-662, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133766
3.
[Dysphagia in a patient with postcricoidal lesion]. / Schluckbeschwerden bei einer Patientin mit postcricoidaler Raumforderung.
Laryngorhinootologie
; 97(2): 115-117, 2018 02.
Artigo
em Alemão
| MEDLINE | ID: mdl-29207436
4.
Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung Cancer.
Clin Nucl Med
; 48(4): 309-314, 2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754127
5.
Somatostatin Receptor-Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas.
Clin Nucl Med
; 48(11): 923-927, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37756444
6.
Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [18F]FDG.
Am J Nucl Med Mol Imaging
; 13(5): 208-216, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023816
7.
Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma.
Endocrine
; 78(1): 169-176, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751778
8.
Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy.
Clin Nucl Med
; 47(6): 512-516, 2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439187